Belite Bio, Inc Market Cap
| Dec'22 | Dec'23 | |
|---|---|---|
| Market Cap | $19.6K | $1,295.5M |
Belite Bio, Inc (BLTE) Market Cap comparison analysis
General
LTM Market Cap
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
BLTE key stats
| Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|
% growth | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.2 | 0.4 |
% margin | (0.0) 0.0% | (0.0) 0.0% | (0.2) 0.0% | (0.4) 0.0% |
| Operating Expenses | 5.7 | 9.8 | 12.8 | 31.7 |
| Research & Development Expenses (R&D) | 3.7 | 7.4 | 8.9 | 24.8 |
| Selling, General & Administrative Expenses (SG&A) | 2.1 | 2.4 | 4.0 | 6.8 |
% margin | (5.7) 0.0% | (9.8) 0.0% | (12.8) 0.0% | (31.7) 0.0% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.1 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 |
| Pre-tax Income | (5.8) | (9.7) | (12.6) | (31.6) |
% effective tax rate | 0.0 (0.0%) | 0.1 (1.3%) | (0.2) 1.4% | 0.0 (0.0%) |
% margin | (5.8) 0.0% | (9.8) 0.0% | (12.5) 0.0% | (31.6) 0.0% |
| EPS | (0.24) | (0.41) | (0.62) | (1.19) |
| Diluted EPS | (0.24) | (0.41) | (0.62) | (1.19) |
% margin | (5.7) 0.0% | (9.6) 0.0% | (12.4) 0.0% | (31.5) 0.0% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Belite Bio, Inc's Market Cap?
As of today, Belite Bio, Inc's last 12-month Market Cap is $1,411.6M, based on the financial report for Sep 27, 2024 (Q3’2024).
2) What is Belite Bio, Inc's Market Cap growth rate?
Over the last year, Belite Bio, Inc's Market Cap growth was 62.3%. The average annual Market Cap growth rates for Belite Bio, Inc have been 37.5% over the past three years, 21.1% over the past five years.
3) Is Belite Bio, Inc's Market Cap growth rate Good?
Over the last year, Belite Bio, Inc's Market Cap growth was 62.3%, which is higher than industry growth of (0.0%). It indicates that Belite Bio, Inc's Market Cap growth is Good.